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Abstract
Background: Arterial diameter and intima-media thickness (IMT) enlargement may each be related to the atherosclerotic
process. Their separate or combined enlargement may indicate different arterial phenotypes with different atherosclerosis risk.
Methods: We investigated cross-sectional (baseline 1987–89: n = 7956) and prospective (median follow-up = 5.9 years: n =
4845) associations between baseline right common carotid artery (RCCA) external diameter and IMT with existing and incident
carotid atherosclerotic lesions detected by B-mode ultrasound in any right or left carotid segments. Logistic regression models
(unadjusted, adjusted for IMT, or adjusted for IMT and risk factors) were used to relate baseline diameter to existing carotid
lesions while comparably adjusted parametric survival models assessed baseline diameter associations with carotid
atherosclerosis progression (incident carotid lesions). Four baseline arterial phenotypes were categorized as having 1) neither
IMT nor diameter enlarged (reference), 2) isolated IMT thickening, 3) isolated diameter enlargement, and 4) enlargement of both
IMT and diameter. The association between these phenotypes and progression to definitive carotid atherosclerotic lesions was
assessed over the follow-up period.
Results: Each standard deviation increment of baseline RCCA diameter was associated with increasing carotid lesion prevalence
(unadjusted odds ratio [OR] = 1.54, 95% confidence interval [CI] = 1.47–1.62) and with progression of carotid atherosclerosis
(unadjusted hazards ratio (HR) = 1.37, 95% CI = 1.28–1.46); and the associations remained significant even after adjustment for
IMT and risk factors (prevalence OR = 1.11, 95% CI = 1.04–1.18; progression HR = 1.11, 95% CI = 1.03–1.19). Controlling for
gender, age and race, persons with both RCCA IMT and diameter in the upper 50th percentiles had the greatest risk of
progressing to clearly defined carotid atherosclerotic lesions (all HR = 1.71, 95% CI = 1.47–2.0; men HR = 1.88, 95% CI = 1.48–
2.39; women HR = 1.59, 95% CI = 1.31–1.95) while RCCA IMT or diameter alone in the upper 50th percentile produced
significantly lower estimated risks.
Conclusion: RCCA IMT and external diameter provide partially overlapping information relating to carotid atherosclerotic
lesions. More importantly, the RCCA phenotype of coexistent wall thickening with external diameter enlargement indicates
higher atherosclerotic risk than isolated wall thickening or diameter enlargement.
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Background
Risk factors contribute to atherosclerosis through gradual
arterial changes that may produce ischemia by either pro-
gressive luminal narrowing or more commonly, by sud-
den plaque rupture or intimal erosions with formation of
an in situ occlusive thrombus [1]. A widely accepted, con-
venient marker of atherosclerosis is carotid artery intima-
media thickness (IMT) [2] which is significantly associ-
ated with prevalent [3,4] and incident [5] carotid plaques.
While a number of factors can contribute to error in ultra-
sound artery measurements [6,7], variation in the progres-
sion of atherosclerosis at different arterial sites, and not
error in ultrasound measurements, is thought to contrib-
ute to some discrepancies in the prediction of coronary
events [8]. However, arterial parameters other than IMT
may provide insights into how risk factors are related to
different stages of atherosclerosis [9-11], promote an
understanding of arterial segment differences [12], or pro-
vide understanding of how classification based on carotid
ultrasound and coronary angiography may differ [13].
Since arterial wall area incorporates both diameter and
wall thickness, area estimation may provide some advan-
tages to IMT alone [14,15]. If different cardiovascular risk
factors are associated with disparate changes in IMT and
diameter, or the parameter changes are manifested at dif-
ferent stages of disease progression, then considering both
measures jointly may identify the atherosclerotic pheno-
types more effectively [13,16-18]. The relationship of
plaques, IMT, and artery diameter is complex and a
number of arterial phenotype classifications have been
proposed [18-24]. Risk factors are associated with arterial
wall thickness [25], IMT progression [26-28], artery diam-
eter [29-31], and calcified carotid plaques [32]. Correla-
tions between carotid IMT and diameter (0.31 to 0.59)
[29,31,33] vary across populations and may depend upon
whether the internal or external diameter [31] is evalu-
ated. Part of the correlation may reflect an adaptive proc-
ess used to maintain arterial wall stress [33-35], but in the
presence of vulnerable atherosclerotic plaques, arterial
diameter may reflect direct damage of the internal elastic
lamina and arterial media [36,37]. So, risk factors may
contribute to IMT and diameter directly and indirectly.
The current study suggests that combined wall thickening
and diameter enlargement indicates a higher risk arterial
phenotype than either isolated abnormality. This may be
relevant to the pathobiology of atherosclerosis.
Methods
Study sample
The ARICLAD (Atherosclerosis Risk in Communities Lim-
ited Access Data) is a subset of the ARIC Study database (N
= 15792) [38] limited to participants whose informed
consent agrees to data sharing (n = 15732, 99.6%). The
sampling strategy for the ARIC Cohort Study has been
reported previously [39], and the ARIC Study procedures
are available [38]. The current study was approved by the
University of Arkansas for Medical Sciences Institutional
Review Board. In brief, this study uses data collected pri-
marily at clinical exams that recurred on average at 3 year
intervals from the 1987–89 baseline exams through the
fourth exam cycle that ended in 1998. The ARIC partici-
pants (15792 black and non-black men and women, ages
45 to 64 at baseline) were recruited from four centers in
the U.S. as previously described [39]. The ARICLAD was
divided randomly into developmental and test datasets
(10000 and 5732 persons, respectively) to be used in sev-
eral studies. For this study, participants missing the fol-
lowing baseline information were excluded: status of
plaques/shadowing at any carotid site (n = 3915), RCCA
diameter, IMT, measures needed for calculation of arterial
wall area (circular or elliptical) (n = 2576), or model 3
covariates (n = 1285). After exclusions, 7956 participants
remained, of which 5015 in the developmental subset
were used to develop cross-sectional models. Excluding
participants with baseline plaques/shadowing (n = 2955)
and those who had no follow-up data on plaques/shad-
owing (n = 156) left 4845 participants of which 3060 were
used to develop the models of atherosclerosis progression
with incident carotid lesions as the outcome. Potential
covariates included race, gender, and baseline age, height,
current smoking status, cigarette years of smoking (based
on years of smoking and numbers of cigarettes smoked
per day), current drinking status, usual ethanol consump-
tion (grams per week calculated from self-reported usual
drinks per week), body mass index (BMI = weight in kilo-
grams/height in meters2), diabetes status, blood glucose,
cholesterol medication use, systolic and diastolic brachial
blood pressure (mm Hg, means of second and third sit-
ting measurements), anti-hypertensive medication use,
fibrinogen, HDL- and LDL-cholesterol, peripheral white
blood count, and physical activity (sport index) [40].
B-mode ultrasound
B-mode ultrasound scans were performed at baseline and
at exam 2 on most participants and on overlapping sub-
sets of participants at exams 3 and 4 [38]. Detailed ultra-
sound methods can be found on the ARIC Limited Access
Data Navigation System under Ultrasound Manuals. The
CCA IMT and external diameter (interadventitial dis-
tance) measures, as defined by ARIC in the "optimal' view
were the primary independent variables investigated.
Because of more complete information on the right than
the left CCA, the right-sided measures were primary and
the left-sided measures were secondary. Plaques were not
intentionally excluded from IMT and diameter measure-
ments and likely contribute to variability of measure-
ments. Presence of carotid atherosclerotic lesions
(plaques or shadowing) was determined from scans of all
right and left carotid artery segments (CCA, bifurcation,Cardiovascular Ultrasound 2008, 6:10 http://www.cardiovascularultrasound.com/content/6/1/10
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and internal carotid artery) [41]. The presence of plaques
was defined during ultrasound reading based on wall
thickness and arterial wall roughness, loss of alignment,
or protrusion into the lumen [42]. Calcification or miner-
alization, another indicator of atherosclerosis, was based
on acoustic shadowing (shadowing) [41]. For the current
study, a carotid atherosclerotic lesion was defined as miss-
ing if any of the six carotid sites had missing data for
plaque/shadowing status and another carotid site was not
positive. Because relatively complete information from all
six carotid sites at baseline (including the CCA, bulb and
the internal carotid segments) was required to construct
the carotid lesion variable, a substantial number of partic-
ipants (N = 3915) had missing baseline information.
Right CCA wall areas
RCCA wall area was calculated as the total artery area
minus the lumen area assuming a circular lumen and an
outer artery structure that was either circular or elliptical.
The formula A = πr2 - π(r - IMT)2 where A is the arterial
wall area, r is the artery radius, and IMT is wall thickness
was used to estimate wall area assuming circular configu-
rations [14,15]. Wall area calculations based on an ellipti-
cal outer artery structure were performed as previously
described [43].
Statistical Methods
All analyses were performed using SASv9 (SAS Institute
Inc., Cary, NC). Two multivariable adjustment methods,
logistic regression and parametric time-to-event models
allowing for interval censoring (SAS LIFEREG procedure
assuming the Weibull distribution of event time), were
the main analytical tools. Associations between one
standard deviation (SD) increments of the baseline vascu-
lar measures with plaques/shadowing were assessed for
the full sample and gender subsets. The unadjusted model
(model 1) included RCCA IMT, diameter, wall area, or
both IMT and diameter (IMT+diameter). Model 2 added
race, age, height, and gender (in the overall model). Two
risk factor adjusted models were used: model 4 included
all 20 covariates while a more parsimonious model
(model 3) included only covariates identified by stepwise
logistic regression analyses as significant (p < 0.05) in at
least one of the vascular measure models. To investigate
the association of arterial diameter enlargement with
atherosclerosis progression, we excluded persons with
carotid lesions at baseline and assessed whether baseline
RCCA diameter predicted the development of readily
identifiable new plaques or shadowing in any carotid site
during follow-up. Covariates were similarly selected in the
prospective models as in the cross-sectional model. See
tables for model 3 covariates. The c-statistic for logistic
regression models was used to assess individual discrimi-
nation for each model.
We also investigated the association of four arterial phe-
notypes at baseline with carotid atherosclerosis progres-
sion. The baseline arterial phenotypes consisted of
isolated or concurrent enlargement of RCCA diameter and
IMT or neither (See Figure 1). The 50th percentile value of
each vascular parameter for men and women was used to
classify persons as having an enlarged RCCA IMT (men:
≥0.66 mm; women: ≥0.61 mm) and/or diameter (men:
≥8.06 mm; women: ≥7.30 mm). To check the robustness
of this approach, separate categorizations were based on
the observed to expected ratio values for IMT and diame-
ter. Expected IMT and diameter values were calculated for
each participant based on gender-specific betas for age,
race, and height determined from linear regression analy-
ses performed on a subset of participants who were free of
atherosclerotic-related conditions (carotid atherosclerotic
lesions, stroke, coronary heart disease, diabetes mellitus,
hypertension [definition includes use of medication], ever
smokers, use of cholesterol lowering medication, BMI ≥
30, or LDL-cholesterol >160 mg/dl) at baseline. The
observed/expected ratios for the RCCA parameter were
ranked and persons in the upper 50th percentile were clas-
sified as having the RCCA measure enlarged.
Results
Out of 20 tested risk factors and characteristics only one,
diabetes status, was statistically significantly (p < 0.05)
different between the developmental and test datasets
(8.8% in the developmental and 10.3% in the test data
set). This difference is modest, and while significant, is
consistent with what would be expected by chance.
Overall, 2955 (37.1%) participants had atherosclerotic
lesions in at least one carotid segment at baseline. Com-
pared to participants without plaques/shadowing (Table
1), participants with lesions were older and were more
likely to be current and former smokers, former drinkers,
diabetics, and use anti-hypertensive and cholesterol-low-
ering medications. Lifetime abstainers from smoking and
drinking were more common among those without base-
line carotid lesions. Among current users, the reported
quantity of cigarettes smoked over their lifetime and usual
ethanol consumption was higher among persons with
than those without carotid lesions. Persons with lesions
were also found to have less favorable levels of systolic
blood pressure, LDL-cholesterol, HDL-cholesterol, fibrin-
ogen, white blood count, and blood glucose compared to
persons without lesions; while diastolic blood pressure,
and sport index were similar in both groups. BMI and the
proportion of black participants were higher among per-
sons without than among those with carotid lesions. After
adjusting for gender, persons with carotid lesions were
shorter than those without lesions. Height- and gender-
adjusted RCCA wall thickness, diameter and calculatedCardiovascular Ultrasound 2008, 6:10 http://www.cardiovascularultrasound.com/content/6/1/10
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wall areas were larger among persons with than among
those without carotid lesions.
In unadjusted cross-sectional models, SD units of IMT
(OR = 1.75), diameter (OR = 1.54), and calculated circular
RCCA wall area (OR = 1.83) were significantly associated
with increased prevalence of carotid atherosclerosis
(Table 2). Adjustment for demographic factors and height
(model 2) or statistically significant risk factors (model 3)
reduced the strength of associations as did inclusion of
both RCCA IMT and diameter in the same model; how-
ever IMT, diameter and wall area all remained statistically
significant (P < 0.05) at all levels of adjustment in the full
sample and in the gender subsets. Inclusion of all 20 risk
factors did not further reduce the odds ratios and all vas-
cular measures remained statistically significant (data not
shown). Since IMT was used by ARIC in defining plaques
[42], the robust association of IMT with carotid lesions
was not unexpected. The stronger RCCA wall area associ-
ation with prevalent carotid lesions among women com-
pared to men in unadjusted analyses (model 1) were no
longer significantly different after controlling for athero-
sclerotic risk factors (model 3).
For prospective studies, the median and maximum fol-
low-up times were 5.9 and 11.7 years respectively. The
strength of the unadjusted, prospective associations for
baseline RCCA IMT (HR = 1.43), diameter (HR = 1.37),
and wall area (HR = 1.50) (Table 3) were weaker than the
comparable cross-sectional associations (Table 2), but
each of the vascular parameters was statistically signifi-
cantly associated with carotid atherosclerosis progression
at all levels of adjustment in the single vascular models
used to evaluate the full sample and the gender subsets
(Table 3). Included together in the same prospective mod-
els, both IMT and diameter remained statistically associ-
ated with incident carotid lesions (progression) at all
levels of adjustment of the full sample, and after basic
adjustment (model 2) in the gender subsets. Diameter's
gender-specific associations with carotid atherosclerosis
progression after adjustment for IMT and risk factors were
similar in magnitude to the cross-sectional associations
for men and women, but in the smaller prospective sam-
ple, the diameter associations were of borderline statisti-
cal significance. To evaluate whether unidentified plaques
in the RCCA at baseline contributed to the positive asso-
ciation between baseline diameter and carotid atheroscle-
rosis progression, we did a sensitivity analysis where we
evaluated the association between exam 1 vascular meas-
ures in longitudinal models restricted to persons without
RCCA plaques at the second exam. RCCA diameter
remained statistically significantly related to carotid
atherosclerosis progression in the overall sample with
only modest attenuation of the strength of association
(Table 3 restricted models).
Sequential adjustment indicates there is overlap in the
excess risk explained by IMT and diameter (Table 3). For
example, the hazard ratio for diameter was reduced from
1.37 to 1.25 after inclusion of IMT in the model. Adjusting
for risk factors, but not IMT, reduced the hazard ratio from
1.37 to 1.17. Adjustment for both IMT and risk factors
reduced the hazard ratio to 1.11. Similarly, IMT risk was
reduced after adjusting for diameter and risk factors, but
with a stronger risk remaining (HR = 1.19).
When categorized by the median values of RCCA IMT and
diameter, 32.0% of participants had both IMT and diam-
Representation of four arterial phenotypes based on enlargement of arterial wall thickness and external diameter Figure 1
Representation of four arterial phenotypes based on enlargement of arterial wall thickness and external diameter. EEM = inter-
face of media and adventitia. IMT = indicates normal intima-media thickness. L = interface of intima with lumen. Large bracket 
indicates normal external diameter.




LCardiovascular Ultrasound 2008, 6:10 http://www.cardiovascularultrasound.com/content/6/1/10
Page 5 of 11
(page number not for citation purposes)
eter enlarged, 18.4% had isolated IMT enlargement,
17.8% had isolated diameter enlargement, and 31.9%
had neither enlarged while categorization based on the
RCCA 50th percentile observed/expected ratios produced
proportions of 30.9%, 19.1%, 19.1%, and 30.9% respec-
tively. These two methods of cross-classification varied
significantly with 83.7% agreement as to having both IMT
and diameter enlarged, 83% as to having neither enlarged,
and 79–80% as to having only one parameter enlarged (p
< 0.0001). However, in general, persons having enlarge-
ment of both RCCA diameter and IMT had the greatest
risk of carotid atherosclerosis progression (risk of incident
plaques) (Figure 2). Controlling for age, race, and sex, per-
sons with both RCCA IMT and diameter in the upper 50th
percentiles of the sample had significantly increased risk
of developing a readily identifiable carotid lesion com-
pared to persons having neither abnormality and to per-
sons having just one of the parameters enlarged. For
women, isolated enlargement of RCCA IMT or diameter
(measure in the upper 50th percentile) did not produce a
significant increase in risk of developing a carotid lesion;
but for men, isolated RCCA IMT enlargement did result in
significantly increased risk of developing a carotid lesion
compared to men with neither parameter enlarged. Simi-
larly, when enlargement was based on the upper 50th per-
Table 1: Characteristics of all participants and of subsets with and without carotid lesions at baseline, Atherosclerosis Risk in 
Communities Limited Access Data, 1987–89.
Full Study Carotid Lesions:
Sample Present Absent
N = 7956 N = 2955 N = 5001 p-value
Age, years (mean (SD)) 54.0 (5.7) 55.7 (5.5) 53.0 (5.6) <0.0001
Male Gender (%) 43.4 52 38.3 <0.0001
Black race (%) 22.6 21.1 23.4 0.02
Smoker (%) Current 25.6 31.7 21.9 <0.0001
Former 31.4 34.2 29.8
N e v e r 4 3 . 03 4 . 24 8 . 3
Cigarette years* (mean (SD)) 660 (418) 735 (449) 596 (379) <0.0001
Drinker (%) Current 58.5 58.6 58.4 0.0002
Former 17.3 19.3 16.1
N e v e r 2 4 . 22 2 . 02 5 . 4
Ethanol, grams/week† (mean (SD)) 72 (111) 79 (125) 60 (102) <0.0001
Diabetes (%) 8.8 10.3 7.9 0.0002
Hypertension medication (%) 24.6 36.5 26.8 <0.0001
Cholesterol medication (%) 2.8 3.4 2.4 0.011
Body Mass Index (mean (SD)) 26.7 (4.6) 26.5 (4.4) 26.8 (4.7) 0.0032
Systolic BP, mm Hg (mean (SD)) 120 (18) 123 (19) 118 (17) <0.0001
Diastolic BP, mm Hg (mean (SD)) 72.7 (10.9) 73.0 (11.0) 72.6 (10.9) 0.146
LDL-C, mmol/L (mean (SD)) 3.53 (1.00) 3.69 (0.98) 3.44 (1.01) <0.0001
HDL-C, mmol/L (mean (SD)) 1.38 (0.45) 1.32 (0.43) 1.41 (0.46) <0.0001
Fibrinogen, mg/dL (mean (SD)) 298 (63) 305 (64) 294 (62) <0.0001
White blood count, 1000s/µL (mean (SD)) 6.0 (1.9) 6.3 (2.0) 5.9 (1.8) <0.0001
Blood glucose, mg/dL (mean (SD)) 105 (33) 107 (36) 104 (31) <0.0001
Sport index (mean (SD)) 2.47 (0.80) 2.48 (0.79) 2.47 (0.81) 0.34
Standing height, cm (mean (SE)) ‡ 168.5 (0.1) 169 (0.11) 169.6 (0.09) <0.0001
RCCA measures (mean (SE)) §
Intima-medial thickness (mm) 0.65 (0.002) 0.71 (0.003) 0.63 (0.002) <0.0001
Diameter (mm) 7.72 (0.01) 7.94 (0.01) 7.65 (0.01) <0.0001
Circular wall area (mm2) 14.6 (0.05) 16.2 (0.08) 13.9 (0.06) <0.0001
Elliptical wall area (mm2) 20.9 (0.06) 22.8 (0.09) 20.1 (0.07) <0.0001
BP = blood pressure.
IMT = intima-media thickness.
RCCA = right common carotid artery.
SD = standard deviation.
SE = standard error.
N = Maximum number possible. Lower numbers were available for some variables because of missing information.
* Among current smokers.
†Among current drinkers.
‡Height is adjusted for gender in the carotid lesion subsets.
§ RCCA measures are adjusted for height and gender in the carotid lesion subsets.Cardiovascular Ultrasound 2008, 6:10 http://www.cardiovascularultrasound.com/content/6/1/10
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centiles of the ratios of the observed/expected RCCA
carotid parameters produced qualitatively similar results.
Substituting LCCA parameter values in the prospective
statistical models (N = 4187) produced results similar to
those for the RCCA measures after adjusting for demo-
graphic factors and height (LCCA wall area HR = 1.37,
95% CI = 1.27–1.49; IMT HR = 1.30, 95% CI = 1.20–1.41;
diameter HR = 1.26, 95% CI = 1.17–1.37) and after
adjusting for 20 risk factors (LCCA wall area HR = 1.25,
95% CI = 1.14–1.35; LCCA IMT HR = 1.20, 95% CI =
1.11–1.30, LCCA diameter HR = 1.15, 95% = 1.06–1.25).
Using LCCA values to define IMT and diameter enlarge-
ment, produced age-, race-, and gender-adjusted associa-
tions qualitatively similar to those for the RCCA (Figure 2)
with the strongest risk of developing carotid lesions gen-
erally occurring among those with both LCCA IMT and
external diameter enlargement.
Using the c-statistic to indicate model discrimination for
the existence of carotid lesions, wall area led to a slight
improvement in model discrimination (c-statistics for
wall area: all 0.650, men: 0.636, women 0.633) compared
to IMT (c-statistics for IMT: all 0.635, men 0.631, women
0.623). However, after adjusting for age, race, height and
gender essentially no difference in risk discrimination
remained (not shown).
Discussion
Arterial wall thickening and diameter enlargement are
intimately related with the anatomic changes generally
proceeding in tandem which produces a complex rela-
tionship between the two parameters and atherosclerosis.
The current study confirmed the overlapping atheroscle-
rosis information provided by risk factors, wall thickness,
and external diameter. More importantly, this study pro-
vides striking evidence that the arterial phenotype of co-
existent wall thickening and diameter enlargement poses
the greatest risk of atherosclerosis progression. The study
proposes a method for determining "normal" artery
parameters that may have general relevance to the classifi-
cation of arterial structure.
Since wall thickening and arterial remodeling do not gen-
erally proceed independently but are linked by adaptive
responses [33,35,44], IMT and diameter provide overlap-
ping information in regards to the risk of atherosclerosis
progression which is clearly evident from the sequential
model adjustments. Only a modest independent relation-
ship between the continuous diameter measure and
atherosclerosis progression remained after adjustment for
Table 2: Cross-sectional associations* between 1-standard deviation (SD) increments of B- mode ultrasound right common carotid 
artery (RCCA) measures and prevalent carotid atherosclerotic lesions for the full sample and by gender, Atherosclerosis Risk in 
Communities Limited Access Data, 1987–1989.
Odds Ratio (95% Confidence Interval)
Full Sample Men Women
RCCA Measure Adjustment Level† N = 7956 N = 3453 N = 4503
IMT Model 1 1.75 (1.66–1.84) 1.67 (1.55–1.80) 1.72 (1.59–1.86)
Model 2 1.54 (1.46–1.53) 1.53 (1.41–1.65) 1.56 (1.44–1.69)
Model 3 1.46 (1.38–1.55) 1.46 (1.34–1.58) 1.47 (1.36–1.60)
Diameter Model 1 1.54 (1.47–1.62) 1.41 (1.31–1.51) 1.55 (1.43–1.67)
Model 2 1.36 (1.29–1.44) 1.32 (1.23–1.42) 1.41 (1.30–1.53)
Model 3 1.24 (1.17–1.32) 1.25 (1.15–1.35) 1.25 (1.15–1.37)
Wall area Model 1 1.83 (1.73–1.92) 1.68 (1.56–1.81) 1.85 (1.71–2.01)
Model 2 1.61 (1.52–1.70) 1.54 (1.43–1.66) 1.69 (1.55–1.84)
Model 3 1.49 (1.41–1.59) 1.47 (1.36–1.59) 1.54 (1.41–1.69)
Model 1
IMT 1.56 (1.47–1.65) 1.56 (1.44–1.69) 1.56 (1.44–1.70)
Diameter 1.31 (1.24–1.38) 1.19 (1.11–1.29) 1.28 (1.17–1.39)
Model 2
IMT 1.46 (1.37–1.54) 1.45 (1.33–1.57) 1.46 (1.35–1.59)
Diameter 1.19 (1.13–1.27) 1.17 (1.08–1.26) 1.23 (1.12–1.34)
Model 3
IMT 1.42 (1.33–1.50) 1.41 (1.30–1.53) 1.43 (1.32–1.56)
Diameter 1.11 (1.04–1.18) 1.12 (1.03–1.22) 1.10 (1.01–1.21)
IMT = intima-media thickness.
*Odds ratios for 1 standard deviation increments of intima-medial thickness (IMT), diameter, wall area (calculated as described in the methods).
†Level of adjustment: Model 1 includes the vascular measure(s) only; Model 2 adds age, race, gender (for the full sample), and height; Model 3 
includes age, gender (for the full sample), cigarette years, body mass index, blood pressure medication use, systolic and diastolic blood pressures, 
LDL- and HDL-cholesterol, white blood count, and cholesterol medication use.Cardiovascular Ultrasound 2008, 6:10 http://www.cardiovascularultrasound.com/content/6/1/10
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both wall thickness and traditional risk factors. This
model improvement could be merely because diameter
improves model calibration[45] or because the diameter
reflects anatomic features that have an auto-catalyzing
effect such as wall inflammation [23,36,46], or because
diameter reflects a risk factor/genetic milieu with a gener-
ally greater propensity for progression, but separating
these possibilities was not part of this study.
As reviewed, both resistance arteries [20] and larger con-
duit arteries [21,47] are subject to anatomic changes that
can be categorized based on diameter and wall thickness
in multiple ways as different arterial phenotypes [18,20-
23]. Kiechl et al found that plaques developed preferen-
tially at sites where the IMT was greater than the 50th per-
centile [48] Our study extends Kiechl's study by showing
that the RCCA phenotype with both diameter and IMT in
the upper 50th percentile had a significantly greater pro-
pensity for progression to definitive carotid lesions than
when only IMT was enlarged. Isolated RCCA diameter
enlargement generally had an even lower risk than iso-
lated wall thickening, but the disparity was not statisti-
cally different. In a recent clinical study, a positive
remodeling index was significantly related to an increase
in diffuse in-stent restenosis [46]. Our results seem to sug-
gest that diameter enlargement in the presence of wall
thickening indicates some fundamental differences from
isolated wall thickening. Just as atherosclerotic plaques
Table 3: Hazards ratios and 95% confidence intervals* for progression to carotid atherosclerotic lesions associated with each standard 
deviation increment of B-mode ultrasound right common carotid artery (RCCA) measures, Atherosclerosis Risk in Communities 
Limited Access Data (ARICLAD), 1987–1998.
Hazards Ratios (95% Confidence Intervals)*
RCCA Measure Adjustment Level† Full Sample Men Women
N = 4845 N = 1850 N = 2995
IMT Model 1 1.43 (1.33–1.53) 1.38 (1.24–1.53) 1.40 (1.27–1.54)
Model 2 1.30 (1.20–1.40) 1.29 (1.16–1.44) 1.30 (1.18–1.44)
Model 3 1.23 (1.14–1.32) 1.23 (1.10–1.37) 1.23 (1.12–1.36)
Model 4 1.23 (1.14–1.32) 1.26 (1.13–1.41) 1.22 (1.11–1.35)
Restricted‡ 1.19 (1.11–1.28) 1.20 (1.08–1.36) 1.20 (1.09–1.32)
Diameter Model 1 1.37 (1.28–1.46) 1.27 (1.14–1.40) 1.36 (1.23–1.50)
Model 2 1.25 (1.17–1.35) 1.23 (1.11–1.36) 1.29 (1.16–1.42)
Model 3 1.17 (1.08–1.25) 1.16 (1.05–1.29) 1.17 (1.06–1.30)
Model 4 1.16 (1.08–1.25) 1.16 (1.04–1.30) 1.17 (1.05–1.29)
Restricted‡ 1.14 (1.05–1.23) 1.12 (1.00–1.25) 1.16 (1.05–1.29)
Wall area Model 1 1.50 (1.40–1.61) 1.40 (1.27–1.56) 1.50 (1.36–1.66)
Model 2 1.36 (1.26–1.47) 1.32 (1.19–1.47) 1.41 (1.26–1.57)
Model 3 1.26 (1.17–1.36) 1.25 (1.12–1.39) 1.29 (1.16–1.43)
Model 4 1.26 (1.17–1.36) 1.27 (1.14–1.42) 1.28 (1.15–1.42)
Restricted‡ 1.22 (1.13–1.32) 1.21 (1.08–1.36) 1.26 (1.13–1.40)
Model 1
IMT 1.29 (1.20–1.39) 1.31 (1.17–1.46) 1.30 (1.17–1.44)
Diameter 1.25 (1.17–1.34) 1.16 (1.04–1.29) 1.23 (1.11–1.36)
Model 2
IMT 1.23 (1.14–1.33) 1.23 (1.10–1.38) 1.23 (1.11–1.37)
Diameter 1.17 (1.09–1.27) 1.15 (1.03–1.28) 1.20 (1.08–1.34)
Model 3
IMT 1.19 (1.10–1.28) 1.19 (1.07–1.33) 1.20 (1.08–1.32)
Diameter 1.11 (1.03–1.19) 1.11 (0.99–1.23) 1.11 (0.99–1.23)
Model 4
IMT 1.19 (1.11–1.29) 1.23 (1.09–1.38) 1.19 (1.07–1.31)
Diameter 1.10 (1.02–1.19) 1.10 (0.98–1.23) 1.11 (0.99–1.23)
Restricted‡
IMT 1.16 (1.08–1.25) 1.18 (1.05–1.33) 1.17 (1.05–1.29)
Diameter 1.09 (1.01–1.18) 1.07 (0.95–1.20) 1.11 (1.00–1.24)
IMT = intima-media thickness.
*Hazards ratio for carotid atherosclerosis progression associated with each standard deviation (SD) increment of the vascular measure(s) (IMT, 
diameter, calculated circular wall area, or IMT and diameter) estimated using SAS LIFEREG procedure using interval censoring.
†Model 1 includes the vascular measure(s) only; Model 2 adds age, race, sex, and height; Model 3 includes age, (gender only in full data set), cigarette 
years of smoking, BMI, systolic and diastolic blood pressures, LDL-cholesterol, and white blood count. Model 4 includes all 20 covariates and was 
limited to the subset with complete data (total n = 4791; n = 1823 for men, and n = 2968 for women).
‡ Restricted Model 4 estimates were made in a subset (total n = 4593; n = 1736 for men, and n = 2857 for women) that excluded persons who 
developed plaques/shadowing in the RCCA by the first follow-up examination.Cardiovascular Ultrasound 2008, 6:10 http://www.cardiovascularultrasound.com/content/6/1/10
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Adjusted* hazards ratios for progression to carotid atherosclerotic lesions for baseline common carotid artery phenotypes†‡ Figure 2
Adjusted* hazards ratios for progression to carotid atherosclerotic lesions for baseline common carotid artery phenotypes†‡. 
*Controlled for age, race and gender. †‡ Isolated or combined IMT and diameter enlargement based on A) observed measures 
and B) observed/expected ratios. Diamond = diameter and IMT enlarged. Square= isolated IMT enlargement. Triangle = iso-
lated diameter enlargement. Solid = right and open = left.
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with expansive remodeling are found to have an inflam-
matory component [36,49], wall thickening with expan-
sive remodeling may also have a greater inflammatory
component [50] or possibly a different genetic suscepti-
bility than walls that do not exhibit expansive remode-
ling. Also, since the ARIC definition of CCA plaques
required the wall to be at least 1.5 mm in thickness,
smaller plaques would be missed. An alternate explana-
tion for the lower risk of atherosclerosis progression
among persons with only IMT thickening could be that
the latter group included persons with non-atheroscle-
rotic thickening such as response to hypertension with
lower flow [18,20]. Evaluating reasons for the different
arterial phenotypes is beyond the scope of the present
study.
This study also presents a possible methodological
improvement in defining arterial phenotypes. Defining
what arterial diameter is normal has been problematic
[21,22] with most recent definitions being based on adja-
cent reference arteries not displaying an atherosclerotic
plaque [21,22]. However, it is widely recognized that sites
free of local lesions can have a generalized dilation
response [51]. A recent assessment of static and serial cor-
onary artery remodeling clearly showed that cross-sec-
tional comparison of sites with atherosclerotic lesions to
a reference artery could result in misclassification of
plaques as having constrictive rather than expansive
remodeling [52]. Our study defined the normal IMT and
diameter values for each person based on the common
carotid arteries of men and women who were free of both
major atherosclerotic disease and of major risk factors
with the gender-specific "normal" values being estimated
for each person's height, age, and race. Thus, the expected
IMT and diameter values to which the observed values are
compared are likely to be free of the effect of major risk
factors and so represent ideal values expected for someone
of similar age, gender, height, and race. This method can
be used for other arterial sites where disease-free and risk
factor-free values are available and could be used to iden-
tify diffuse remodeling, absence of remodeling, and con-
strictive remodeling.
Wall area provides a composite measure of IMT and diam-
eter. However, while wall area did provide a modestly
stronger association with carotid atherosclerosis progres-
sion than IMT, wall area will not distinguish the different
arterial phenotypes that may be important in understand-
ing atherosclerosis progression.
This study has certain limitations. In the study of incident
carotid atherosclerotic lesions (atherosclerosis progres-
sion), the use of the ARIC plaque definition requiring a
thickness of at least 1.5 mm, could have resulted in
smaller plaques being missed at baseline. Others have
shown that pre-existing plaques predicted development of
new plaques and progression of existing plaques [48]. So,
we cannot be sure that diameter enlargement at baseline
was not because of non-diagnosed plaques that had pro-
duced expansive remodeling. Even the sensitivity analysis
that excluded persons with RCCA lesions at exam 2, can-
not exclude this possibility.
The rate of focal arterial remodeling in atherosclerosis
depends upon initial lumen size [53] which complicates
the use of diameter as an indicator of atherosclerosis.
Thus, body stature and age which are correlated with arte-
rial diameter [12,54], could impact the association
between diameter and atherosclerosis. Also, there appears
to be a limit to arteries' ability to enlarge in response to
wall thickening [34] which could limit diameter's useful-
ness as an indicator of atherosclerosis among the elderly.
Our use of a classification of enlargement based on the
observed to expected arterial parameter diminished some
of these concerns. Our results support the contention [9]
that considering arterial diameter as well as wall thickness
is essential in understanding the atherosclerotic process.
Our results may not be representative of the ARIC cohort
as participants without complete data on carotid athero-
sclerosis were excluded. Also, the reader- and trend-
adjusted IMT values used in many ARIC manuscripts were
not available for these analyses. A change of ultrasound
equipment occurred during the third exam and the ultra-
sound protocol was simplified from three views at base-
line to a single view at exams 3 and 4. This could have
contributed to differences in plaques/shadowing recogni-
tion between early and later exams. While diameter meas-
urements may vary depending upon the scan view,
variability was minimized by using measurements from
the view with defined structures. Since vascular measure-
ments did not intentionally exclude plaques, IMT and
diameter measurements at baseline could reflect both
adaptive response and atherosclerosis as discussed above.
In conclusion, B-mode ultrasound-measured RCCA diam-
eter is associated with the progression of atherosclerosis in
the carotid arterial system. A method devised to define the
reference CCA parameters may remove some previous
methodological limitations. Our study suggests that pres-
ence of both external RCCA diameter enlargement as well
as wall thickening may indicate a high risk arterial pheno-
type. Future studies should investigate factors relating to
the different arterial phenotypes as well as how arterial
diameters relate to local or carotid system changes.
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